COMPOSITE PEPTIDE A EMERGING CLINICAL FRONTIER

Chimera molecules represent a significantly evolving domain in drug exploration, presenting a unique strategy to address previously difficult illnesses. These kind of engineered structures integrate multiple peptide regions, enabling for enhanced affinity to multiple targets and potentially avoid